WeVote

Bill

Bill

HF 4002

Veterinary products from the prohibition on products containing PFAS exempted.

2025-2026 Regular Session Introduced by John Burkel

Prohibits sale and use of veterinary products containing PFAS in Minnesota, with specified exemptions for certain previously allowed products.

Introduction and first reading, referred to Environment and Natural Resources Finance and Policy
0
WeVote Research Nonpartisan
Bill Summary · HF 4002

Summary of HF 4002 (Minnesota, 2025-2026 Session)

Overview

HF 4002 introduces a prohibition on veterinary products that contain PFAS (per- and polyfluoroalkyl substances) and specifies exemptions related to products that were previously exempted from that prohibition. The bill appears to address the safety and environmental/health concerns associated with PFAS in veterinary products by setting rules for what can be sold or used in Minnesota.

  • Session: 2025-2026
  • Jurisdiction: Minnesota
  • Title: Veterinary products from the prohibition on products containing PFAS exempted
  • Introduction/Referral: Introduced and first read on 2026-03-05; referred to the Environment and Natural Resources Finance and Policy committee
  • Sponsor: Primary sponsor not listed; co-sponsor: John Burkel

Note: The summary below reflects the stated bill title and the typical structure of such bills. Specific provisions beyond what is implied by the title may appear in the actual bill text.

Purpose and Intent

  • Establish a prohibition on veterinary products that contain PFAS.
  • Create or maintain exemptions related to products that were previously exempted from PFAS-related prohibitions, clarifying which products may still be sold or used.
  • Protect public health and the environment by limiting PFAS exposure through veterinary products.

Key Provisions (Expected Based on Title)

  1. PFAS Prohibition in Veterinary Products

    • Prohibit the sale, distribution, or use of veterinary products containing PFAS within the state.
    • Cover categories such as medicines, vaccines, feed additives, topical treatments, and other approved veterinary products.
  2. Exemptions Related to Prior PFAS Prohibitions

    • Specify exemptions for products that were exempted from PFAS prohibitions previously, or for certain classes of products that are allowed under transitional rules.
    • Define criteria for when an exemption applies (e.g., specific product formulations, approved by regulatory authorities, or products in use before the effective date).
  3. Regulatory Authority and Enforcement

    • Delegate or outline enforcement responsibilities to an appropriate state agency (likely the Minnesota Department of Agriculture, Minnesota Board of Veterinary Medicine, or Department of Environment and Natural Resources).
    • Establish penalties for violations (e.g., fines, compliance orders) and a process for compliance and enforcement.
  4. Effective Dates and Phase-Ins

    • Set effective dates for the prohibition, potentially with phased compliance timelines.
    • Clarify implementation milestones for manufacturers, distributors, and veterinarians/pharmacies.
  5. Reporting and Disclosure

    • May require reporting by producers or distributors of veterinary products containing PFAS prior to the ban.
    • Possible labeling or disclosure requirements to inform users about PFAS content or exemptions.
  6. Definitions

    • Define PFAS and related terms to avoid ambiguity.
    • Provide definitions for terms like “veterinary product,” “exemption,” and “prohibition.”

Affected Parties and Impact

  • Manufacturers and Distributors: Entities that produce or distribute veterinary products may need to reformulate products, remove PFAS-containing items from Minnesota markets, or seek exemptions where applicable.
  • Veterinarians, Pharmacies, and Retailers: Businesses and professionals selling or administering veterinary products would need to ensure compliance with the PFAS prohibition and verify product formulations.
  • Pet Owners and Livestock Producers: Indirectly affected through the availability of PFAS-free veterinary products; potential changes in product availability and pricing.
  • Regulatory Agencies: State agencies would administer the prohibition, monitor compliance, and enforce penalties.

Procedural and Timeline Considerations

  • Introduction and Referral: The bill was introduced and referred on 2026-03-05 to the Environment and Natural Resources Finance and Policy committee.
  • Next Steps: Committee hearings, possible amendments, and floor votes. Subsequent actions would specify exact dates for effective implementation, exemptions, and enforcement timelines.

If you’d like, I can tailor this summary to emphasize the exact text of the provisions once the bill’s full language is available, and add any stated dates, dollar penalties, or exemption conditions as they appear in the enacted version.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.